摘要
目的:探讨影响非小细胞肺癌治疗效果的临床因素。方法:选取2016年1-12月笔者所在医院收治的经病理学和细胞学确诊为非小细胞肺癌的患者60例,分析对患者生存时间具有显著影响的因素。结果:非小细胞癌患者的1年、2年和3年生存率分别为53%、25%和12%;不同病理类型、KPS评分、临床分期、治疗方式、血红蛋白含量、CA-199水平患者的生存时间比较,差异均有统计学意义(P<0.05);临床分期、KPS评分、治疗方式和血红蛋白水平是影响非小细胞肺癌患者生存时间的独立因素(P<0.05)。结论:临床分期、KPS评分、治疗方式和血红蛋白水平使影响非小细胞肺癌患者生存时间的独立因素,可为肺癌的治疗和预后提供依据。
Objective：To explore the clinical factors that influence the therapeutic effect of non-small cell lung cancer.Method：From January 2016 to December 2016,60 patients diagnosed with non-small cell lung cancer by pathology and cytology were selected from the author＇s hospital,and the factors that had a significant impact on the patient＇s survival time were analyzed.Result：The non-small cell lung cancer patients survival rates of 1,2 and 3 years were 53%,25% and 12%,respectively.The differences in the survival time of patients with different pathological types,KPS scores,clinical stages,treatment methods,hemoglobin levels,and CA-199 level were statistically significant（P〈0.05）.Clinical stages,KPS scores,treatment methods and hemoglobin levels were the independent factors that affected the survival time of non-small cell lung cancer patients（P〈0.05）.Conclusion：Clinical stages,KPS scores,treatment methods and hemoglobin levels were the independent factors that affect the survival time of non-small cell lung cancer patients,and it can provide a basis for the treatment and prognosis of lung cancer.
作者
王溪清
WANG Xiqing(Anqing Naval Hospital,Anqing 246001,China)
出处
《中外医学研究》
2018年第13期23-25,共3页
CHINESE AND FOREIGN MEDICAL RESEARCH
关键词
非小细胞肺癌
生存时间
影响因素
Non-small cell lung cancer
Survival time
Influence factor
